MGA Report Cited in Forbes Article on Rising Prescription Drug Prices In his Forbes article, Ike Brannon discusses the blame game being played in Washington in regards to skyrocketing drug prices. In particular, he argues against what he sees as unnecessary blame...
IAM Quotes MGA Report in Article Discussing the Problem of Patent Thickets In his article for Intellectual Asset Management (IAM), Life Sciences Reporter Adam Houldsworth discusses the problems in the U.S. patent system that enable the “thorny”...
Alex Brill Interviewed on Future of US Biosimilars Market In a new BioWorld article, Mari Serebrov discusses efforts by Congress to control US prescription drug prices. Interviewed for the article was MGA’s Alex Brill, who talks about the potential side effects...
MGA’s Christy Robinson Quoted in IAM Article on Patent Thickets In Intellectual Asset Management (IAM), Fresenius Kabi Intellectual Property Chief Rachel Moodie discusses the worsening problem of patent thickets in the U.S. biosimilars market. From IAM:...
MGA Report Comes in at Number One at The Center for Biosimilars The Center for Biosimilars has announced that MGA’s recent report, “How Patent Thickets Constrain the US Biosimilars Market and Domestic Manufacturing,” was the top-read article on its...
MGA Report Featured by The Center for Biosimilars On Thursday, The Center for Biosimilars, a sister site of The American Journal of Managed Care, published an article discussing the differences between the patent systems in the United States and Europe when it comes...
